| 1 | plasma membrane repair (GO:0001778) | 7.92689889 |
| 2 | regulation of skeletal muscle contraction (GO:0014819) | 7.86804526 |
| 3 | regulation of sarcomere organization (GO:0060297) | 7.59543193 |
| 4 | negative regulation of organelle assembly (GO:1902116) | 6.96671162 |
| 5 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 6.95277759 |
| 6 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 6.56891082 |
| 7 | response to muscle activity (GO:0014850) | 6.50268929 |
| 8 | negative regulation of protein localization to cell surface (GO:2000009) | 6.48596691 |
| 9 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.05675005 |
| 10 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 5.96223888 |
| 11 | muscle cell cellular homeostasis (GO:0046716) | 5.93264218 |
| 12 | positive regulation of catecholamine secretion (GO:0033605) | 5.71063563 |
| 13 | membrane raft organization (GO:0031579) | 5.68454293 |
| 14 | negative regulation of muscle hypertrophy (GO:0014741) | 5.55806644 |
| 15 | regulation of p38MAPK cascade (GO:1900744) | 5.49952060 |
| 16 | negative regulation of cell size (GO:0045792) | 5.41967153 |
| 17 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.35500652 |
| 18 | regulation of autophagic vacuole assembly (GO:2000785) | 5.31418696 |
| 19 | myofibril assembly (GO:0030239) | 4.99843997 |
| 20 | coenzyme catabolic process (GO:0009109) | 4.93978572 |
| 21 | regulation of phosphoprotein phosphatase activity (GO:0043666) | 4.72956446 |
| 22 | negative regulation of heart growth (GO:0061117) | 4.66297494 |
| 23 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 4.66297494 |
| 24 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 4.64520980 |
| 25 | regulation of phospholipase A2 activity (GO:0032429) | 4.57304639 |
| 26 | regulation of action potential (GO:0098900) | 4.49754315 |
| 27 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 4.49415051 |
| 28 | activation of protein kinase B activity (GO:0032148) | 4.48883713 |
| 29 | negative regulation of monooxygenase activity (GO:0032769) | 4.37943522 |
| 30 | cardiac myofibril assembly (GO:0055003) | 4.35630283 |
| 31 | ribonucleoprotein complex disassembly (GO:0032988) | 4.21941600 |
| 32 | primary alcohol catabolic process (GO:0034310) | 4.21513410 |
| 33 | striated muscle atrophy (GO:0014891) | 4.19834043 |
| 34 | regulation of vacuole organization (GO:0044088) | 4.18550159 |
| 35 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.08386478 |
| 36 | regulation of cardiac muscle cell differentiation (GO:2000725) | 4.02314324 |
| 37 | cGMP-mediated signaling (GO:0019934) | 4.01100345 |
| 38 | muscle atrophy (GO:0014889) | 3.99078054 |
| 39 | positive regulation of protein kinase C signaling (GO:0090037) | 3.98111446 |
| 40 | positive regulation of myotube differentiation (GO:0010831) | 3.92000056 |
| 41 | organelle disassembly (GO:1903008) | 3.87336594 |
| 42 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.86171104 |
| 43 | cellular response to zinc ion (GO:0071294) | 3.85705660 |
| 44 | diacylglycerol metabolic process (GO:0046339) | 3.83745962 |
| 45 | negative regulation of cardiac muscle tissue development (GO:0055026) | 3.79058573 |
| 46 | ethanol metabolic process (GO:0006067) | 3.70800575 |
| 47 | regulation of oxidative stress-induced neuron death (GO:1903203) | 3.69427434 |
| 48 | muscle cell fate commitment (GO:0042693) | 3.67779825 |
| 49 | regulation of membrane repolarization (GO:0060306) | 3.66947448 |
| 50 | motile cilium assembly (GO:0044458) | 3.66395845 |
| 51 | AMP metabolic process (GO:0046033) | 3.64345056 |
| 52 | positive regulation of myoblast differentiation (GO:0045663) | 3.54340011 |
| 53 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.52418473 |
| 54 | thyroid gland development (GO:0030878) | 3.50479509 |
| 55 | barbed-end actin filament capping (GO:0051016) | 3.46367791 |
| 56 | membrane assembly (GO:0071709) | 3.46307071 |
| 57 | potassium ion export (GO:0071435) | 3.42219617 |
| 58 | cellular response to lithium ion (GO:0071285) | 3.42074713 |
| 59 | cellular response to cadmium ion (GO:0071276) | 3.41671236 |
| 60 | relaxation of smooth muscle (GO:0044557) | 3.41645459 |
| 61 | protein localization to cell surface (GO:0034394) | 3.40373245 |
| 62 | mRNA cleavage (GO:0006379) | 3.37517854 |
| 63 | regulation of oxidative phosphorylation (GO:0002082) | 3.30121543 |
| 64 | TOR signaling (GO:0031929) | 3.26836476 |
| 65 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.21217473 |
| 66 | positive regulation of microtubule polymerization (GO:0031116) | 3.21066914 |
| 67 | regulation of muscle hypertrophy (GO:0014743) | 3.17193638 |
| 68 | sarcomere organization (GO:0045214) | 3.11127908 |
| 69 | regulation of protein localization to cell surface (GO:2000008) | 3.08587395 |
| 70 | muscle filament sliding (GO:0030049) | 3.07275859 |
| 71 | actin-myosin filament sliding (GO:0033275) | 3.07275859 |
| 72 | myoblast migration (GO:0051451) | 3.05789615 |
| 73 | ADP metabolic process (GO:0046031) | 3.05598024 |
| 74 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.04679186 |
| 75 | muscle fiber development (GO:0048747) | 3.04404827 |
| 76 | regulation of alkaline phosphatase activity (GO:0010692) | 3.03786247 |
| 77 | regulation of protein kinase C signaling (GO:0090036) | 3.00540022 |
| 78 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 3.00084860 |
| 79 | regulation of myoblast differentiation (GO:0045661) | 2.98289858 |
| 80 | heart trabecula formation (GO:0060347) | 2.97826858 |
| 81 | response to mercury ion (GO:0046689) | 2.95384116 |
| 82 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.95069637 |
| 83 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.93200687 |
| 84 | multicellular organism reproduction (GO:0032504) | 2.91885475 |
| 85 | myoblast fusion (GO:0007520) | 2.91246087 |
| 86 | androgen biosynthetic process (GO:0006702) | 2.85944530 |
| 87 | actin-mediated cell contraction (GO:0070252) | 2.81976527 |
| 88 | paraxial mesoderm development (GO:0048339) | 2.81493089 |
| 89 | negative regulation of potassium ion transport (GO:0043267) | 2.78327538 |
| 90 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.76417331 |
| 91 | skeletal muscle adaptation (GO:0043501) | 2.75285922 |
| 92 | cellular response to toxic substance (GO:0097237) | 2.72889113 |
| 93 | striated muscle adaptation (GO:0014888) | 2.72198020 |
| 94 | embryonic viscerocranium morphogenesis (GO:0048703) | 2.66669626 |
| 95 | negative regulation of striated muscle cell differentiation (GO:0051154) | 2.66236674 |
| 96 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.65232335 |
| 97 | regulation of hippo signaling (GO:0035330) | 2.65041961 |
| 98 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.64652001 |
| 99 | regulation of ARF GTPase activity (GO:0032312) | 2.63269871 |
| 100 | oligosaccharide biosynthetic process (GO:0009312) | 2.62750439 |
BMS1P3 
